275 related articles for article (PubMed ID: 23802178)
21. Peroxynitrite Exposure of CXCL12 Impairs Monocyte, Lymphocyte and Endothelial Cell Chemotaxis, Lymphocyte Extravasation
Janssens R; Boff D; Ruytinx P; Mortier A; Vanheule V; Larsen O; Daugvilaite V; Rosenkilde MM; Noppen S; Liekens S; Schols D; De Meester I; Opdenakker G; Struyf S; Teixeira MM; Amaral FA; Proost P
Front Immunol; 2018; 9():1933. PubMed ID: 30233568
[TBL] [Abstract][Full Text] [Related]
22. Elucidating a key component of cancer metastasis: CXCL12 (SDF-1α) binding to CXCR4.
Tamamis P; Floudas CA
J Chem Inf Model; 2014 Apr; 54(4):1174-88. PubMed ID: 24660779
[TBL] [Abstract][Full Text] [Related]
23. Preparation and Analysis of N-Terminal Chemokine Receptor Sulfopeptides Using Tyrosylprotein Sulfotransferase Enzymes.
Seibert C; Sanfiz A; Sakmar TP; Veldkamp CT
Methods Enzymol; 2016; 570():357-88. PubMed ID: 26921955
[TBL] [Abstract][Full Text] [Related]
24. The chemokines CCL5 and CXCL12 exhibit high-affinity binding to N-terminal peptides of the non-cognate receptors CXCR4 and CCR5, respectively.
Kessler N; Akabayov SR; Cohen LS; Scherf T; Naider F; Anglister J
FEBS J; 2024 Feb; 291(3):458-476. PubMed ID: 37997026
[TBL] [Abstract][Full Text] [Related]
25. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling.
Levoye A; Balabanian K; Baleux F; Bachelerie F; Lagane B
Blood; 2009 Jun; 113(24):6085-93. PubMed ID: 19380869
[TBL] [Abstract][Full Text] [Related]
26. Sequential tyrosine sulfation of CXCR4 by tyrosylprotein sulfotransferases.
Seibert C; Veldkamp CT; Peterson FC; Chait BT; Volkman BF; Sakmar TP
Biochemistry; 2008 Oct; 47(43):11251-62. PubMed ID: 18834145
[TBL] [Abstract][Full Text] [Related]
27. Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach.
Costantini S; Raucci R; De Vero T; Castello G; Colonna G
Cytokine; 2013 Oct; 64(1):316-21. PubMed ID: 23773308
[TBL] [Abstract][Full Text] [Related]
28. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
Tu CC; Arnolds KL; O'Connor CM; Spencer JV
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
[TBL] [Abstract][Full Text] [Related]
29. Structure-Based Identification of Novel Ligands Targeting Multiple Sites within a Chemokine-G-Protein-Coupled-Receptor Interface.
Smith EW; Nevins AM; Qiao Z; Liu Y; Getschman AE; Vankayala SL; Kemp MT; Peterson FC; Li R; Volkman BF; Chen Y
J Med Chem; 2016 May; 59(9):4342-51. PubMed ID: 27058821
[TBL] [Abstract][Full Text] [Related]
30. Baclofen and other GABAB receptor agents are allosteric modulators of the CXCL12 chemokine receptor CXCR4.
Guyon A; Kussrow A; Olmsted IR; Sandoz G; Bornhop DJ; Nahon JL
J Neurosci; 2013 Jul; 33(28):11643-54. PubMed ID: 23843532
[TBL] [Abstract][Full Text] [Related]
31. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
Khare T; Bissonnette M; Khare S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
[TBL] [Abstract][Full Text] [Related]
32. Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands.
Moussouras NA; Getschman AE; Lackner ER; Veldkamp CT; Dwinell MB; Volkman BF
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28869519
[TBL] [Abstract][Full Text] [Related]
33. Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine.
Qin L; Kufareva I; Holden LG; Wang C; Zheng Y; Zhao C; Fenalti G; Wu H; Han GW; Cherezov V; Abagyan R; Stevens RC; Handel TM
Science; 2015 Mar; 347(6226):1117-22. PubMed ID: 25612609
[TBL] [Abstract][Full Text] [Related]
34. Natural nitration of CXCL12 reduces its signaling capacity and chemotactic activity in vitro and abrogates intra-articular lymphocyte recruitment in vivo.
Janssens R; Mortier A; Boff D; Vanheule V; Gouwy M; Franck C; Larsen O; Rosenkilde MM; Van Damme J; Amaral FA; Teixeira MM; Struyf S; Proost P
Oncotarget; 2016 Sep; 7(38):62439-62459. PubMed ID: 27566567
[TBL] [Abstract][Full Text] [Related]
35. Kinetic Analysis of the Early Signaling Steps of the Human Chemokine Receptor CXCR4.
Perpiñá-Viciano C; Işbilir A; Zarca A; Caspar B; Kilpatrick LE; Hill SJ; Smit MJ; Lohse MJ; Hoffmann C
Mol Pharmacol; 2020 Aug; 98(2):72-87. PubMed ID: 32474443
[TBL] [Abstract][Full Text] [Related]
36. Phosphate modulates receptor sulfotyrosine recognition by the chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2).
Ludeman JP; Nazari-Robati M; Wilkinson BL; Huang C; Payne RJ; Stone MJ
Org Biomol Chem; 2015 Feb; 13(7):2162-9. PubMed ID: 25536525
[TBL] [Abstract][Full Text] [Related]
37. Dimeric peptides of the C-terminal region of CXCL14 function as CXCL12 inhibitors.
Tanegashima K; Tsuji K; Suzuki K; Shigenaga A; Otaka A; Hara T
FEBS Lett; 2013 Nov; 587(23):3770-5. PubMed ID: 24161674
[TBL] [Abstract][Full Text] [Related]
38. Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways.
Drury LJ; Ziarek JJ; Gravel S; Veldkamp CT; Takekoshi T; Hwang ST; Heveker N; Volkman BF; Dwinell MB
Proc Natl Acad Sci U S A; 2011 Oct; 108(43):17655-60. PubMed ID: 21990345
[TBL] [Abstract][Full Text] [Related]
39. Stoichiometry and geometry of the CXC chemokine receptor 4 complex with CXC ligand 12: molecular modeling and experimental validation.
Kufareva I; Stephens BS; Holden LG; Qin L; Zhao C; Kawamura T; Abagyan R; Handel TM
Proc Natl Acad Sci U S A; 2014 Dec; 111(50):E5363-72. PubMed ID: 25468967
[TBL] [Abstract][Full Text] [Related]
40. Structural analysis of a novel small molecule ligand bound to the CXCL12 chemokine.
Smith EW; Liu Y; Getschman AE; Peterson FC; Ziarek JJ; Li R; Volkman BF; Chen Y
J Med Chem; 2014 Nov; 57(22):9693-9. PubMed ID: 25356720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
